70 results
6-K
TAK
Takeda Pharmaceutical Co
2 Feb 24
Current report (foreign)
6:16am
to achieve high levels of subject retention and protocol compliance in endemic regions. The vaccine is approved in multiple endemic and non-endemic countries
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
14 Dec 23
Current report (foreign)
6:01am
Standards for the Professional Practice of Internal Auditing (IIA Standards)” issued by the Institute of Internal Auditors. (ii) System for retention
6-K
TAK
Takeda Pharmaceutical Co
30 Oct 23
Current report (foreign)
6:02am
-generation dengue vaccine, and it considered the
- 15 -
Translation for reference purpose only
need to achieve high levels of subject retention
6-K
TAK
Takeda Pharmaceutical Co
1 Aug 23
Current report (foreign)
6:10am
, and it considered the need to achieve high levels of subject retention and protocol compliance in endemic regions. The vaccine is approved in multiple endemic
6-K
EX-99.1
TAK
Takeda Pharmaceutical Co
12 Jul 23
Current report (foreign)
6:07am
of Internal Auditing (IIA Standards)” issued by the Institute of Internal Auditors. (ii) System for retention and management of information concerning
6-K
EX-99.1
1tq2ze5e
23 Jun 23
Current report (foreign)
6:13am
6-K
igxdtkyv2mj4hj2u
30 May 23
Current report (foreign)
6:20am
6-K
EX-99.1
6u6nr2he 5666sv
30 May 23
Current report (foreign)
6:11am
6-K
55g7or2 7al
11 Jul 22
Current report (foreign)
6:05am
6-K
cgi4rhzal5
31 May 22
Current report (foreign)
6:18am
6-K
EX-99.1
vbno1gc40nypw8xslam
31 May 22
Current report (foreign)
6:07am
6-K
EX-99.1
lo981xb5 ak1s041u
31 May 22
Current report (foreign)
12:00am
6-K
8e3x8g6al7 10xrnx2g6
1 Nov 21
Current report (foreign)
6:04am
6-K
6dgrg5a8 9cxbj
6 Aug 21
Current report (foreign)
6:10am
6-K
hih6l54o
19 Jul 21
Current report (foreign)
6:02am